Measuring depression in Primary Health Care in Spain: Psychometric properties and diagnostic accuracy of HSCL-5 and HSCL-10.
Hopkins Symptom Checklist
Primary Health Care (MeSH)
depression
diagnostic accuracy
patient reported outcome measures (MeSH)
psychometric properties
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
08
2022
accepted:
21
12
2022
entrez:
26
1
2023
pubmed:
27
1
2023
medline:
27
1
2023
Statut:
epublish
Résumé
Depression has a high prevalence among European countries. Several instruments have been designed to assess its symptoms in different populations. The Hopkins Symptom Checklist 25 (HSCL-25) scale has been identified as valid, reproducible, effective, and easy to use. There are short versions of this scale that could be useful in Primary Care (PC) settings, but their psychometric properties are unknown. To assess in PC patients the psychometric properties and diagnostic accuracy of the Spanish version of the HSCL-10 and the HSCL-5 consisting of 10 and 5 items, respectively. A multicenter, cross-sectional study was carried out at six PC centers in Spain. The HSCL-25 was administered to outpatients aged 45-75 who also participated in the structured Composite International Diagnostic Interview (CIDI). HSCL-10 and HSCL-5 were assessed and compared to HSCL-25 regarding total score correlation, internal consistency, and criterion validity against the gold-standard CIDI. This is a methodological study from a secondary data analysis and the primary data has been previously published. Out of 790 patients, 767 completed the HSCL-25 and 736 the CIDI interview (96.0%). Cronbach's Alpha was 0.84 for HSCL-10 and 0.77 for HSCL-5. The known-group method and confirmatory factor analysis were acceptable for the establishment of construct validity. Sensitivity was 79.7% (CI95%, 67.7-88.0%) for HSCL-10, and 78.0% (CI95%, 65.9-86.6%) for HSCL-5, whereas specificity was 83% (CI95%, 80.0-85.7%) for HSCL-10, and 72.8% (CI95%, 69.3-76.0%) for HSCL-5. Area under the curve against CIDI was 0.88 (CI95%, 0.84-0.92%) for HSCL-10, and 0.85 (CI95%, 0.81-0.89%) for HSCL-5. Optimum cutoff point calculated with Youden Index was 1.90 for the HSCL-10 and 1.80 for the HSCL-5. HSCL-10 and HSCL-5 are reliable and valid tools to detect depression symptoms and can be used in PC settings.
Sections du résumé
Background
UNASSIGNED
Depression has a high prevalence among European countries. Several instruments have been designed to assess its symptoms in different populations. The Hopkins Symptom Checklist 25 (HSCL-25) scale has been identified as valid, reproducible, effective, and easy to use. There are short versions of this scale that could be useful in Primary Care (PC) settings, but their psychometric properties are unknown.
Aim
UNASSIGNED
To assess in PC patients the psychometric properties and diagnostic accuracy of the Spanish version of the HSCL-10 and the HSCL-5 consisting of 10 and 5 items, respectively.
Methods
UNASSIGNED
A multicenter, cross-sectional study was carried out at six PC centers in Spain. The HSCL-25 was administered to outpatients aged 45-75 who also participated in the structured Composite International Diagnostic Interview (CIDI). HSCL-10 and HSCL-5 were assessed and compared to HSCL-25 regarding total score correlation, internal consistency, and criterion validity against the gold-standard CIDI. This is a methodological study from a secondary data analysis and the primary data has been previously published.
Results
UNASSIGNED
Out of 790 patients, 767 completed the HSCL-25 and 736 the CIDI interview (96.0%). Cronbach's Alpha was 0.84 for HSCL-10 and 0.77 for HSCL-5. The known-group method and confirmatory factor analysis were acceptable for the establishment of construct validity. Sensitivity was 79.7% (CI95%, 67.7-88.0%) for HSCL-10, and 78.0% (CI95%, 65.9-86.6%) for HSCL-5, whereas specificity was 83% (CI95%, 80.0-85.7%) for HSCL-10, and 72.8% (CI95%, 69.3-76.0%) for HSCL-5. Area under the curve against CIDI was 0.88 (CI95%, 0.84-0.92%) for HSCL-10, and 0.85 (CI95%, 0.81-0.89%) for HSCL-5. Optimum cutoff point calculated with Youden Index was 1.90 for the HSCL-10 and 1.80 for the HSCL-5.
Conclusion
UNASSIGNED
HSCL-10 and HSCL-5 are reliable and valid tools to detect depression symptoms and can be used in PC settings.
Identifiants
pubmed: 36698836
doi: 10.3389/fmed.2022.1014340
pmc: PMC9869680
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1014340Informations de copyright
Copyright © 2023 Rodríguez-Barragán, Fernández-San-Martín, Clavería, Le Reste, Nabbe, Motrico, Gómez-Gómez and Peguero-Rodríguez.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
PLoS One. 2022 Jun 30;17(6):e0270544
pubmed: 35771894
Assessment. 2021 Mar;28(2):617-631
pubmed: 31272193
Acta Psychiatr Scand. 1993 May;87(5):364-7
pubmed: 8517178
Int J Methods Psychiatr Res. 2004;13(2):93-121
pubmed: 15297906
Confl Health. 2020 Jul 09;14:44
pubmed: 32670398
Int J Geriatr Psychiatry. 2002 Mar;17(3):279-87
pubmed: 11921157
Behav Sci. 1974 Jan;19(1):1-15
pubmed: 4808738
Health Qual Life Outcomes. 2021 Oct 27;19(1):248
pubmed: 34706715
Gac Sanit. 2012 Mar;26 Suppl 1:76-81
pubmed: 22047623
Psychiatry Res. 2022 Feb;308:114363
pubmed: 34979381
J Clin Epidemiol. 2015 Sep;68(9):1085-92
pubmed: 25962972
Ann Fam Med. 2009 Sep-Oct;7(5):455-62
pubmed: 19752474
Eur Psychiatry. 2017 Jan;39:99-105
pubmed: 27992813
J Vasc Bras. 2020 Dec 11;19:e20200186
pubmed: 34211533
Psychosomatics. 2009 Nov-Dec;50(6):613-21
pubmed: 19996233
Nutrients. 2021 Aug 07;13(8):
pubmed: 34444884
Lancet Psychiatry. 2022 Feb;9(2):137-150
pubmed: 35026139
Int J Environ Res Public Health. 2021 Jul 24;18(15):
pubmed: 34360136
Qual Prim Care. 2009;17(4):251-61
pubmed: 19807958
Aten Primaria. 2020 Oct;52(8):539-547
pubmed: 32703629
Front Psychiatry. 2021 Aug 12;12:688154
pubmed: 34475830
Int J Environ Res Public Health. 2022 Nov 22;19(23):
pubmed: 36498448
Med Clin North Am. 2017 Jul;101(4):807-821
pubmed: 28577628
BMC Fam Pract. 2016 Jan 27;17:7
pubmed: 26817851
BMC Health Serv Res. 2022 Jan 26;22(1):111
pubmed: 35078477
Compr Psychiatry. 2014 Feb;55(2):396-403
pubmed: 24286991
Fam Pract. 2016 Dec;33(6):740-745
pubmed: 27614099
BMC Geriatr. 2022 Oct 7;22(1):788
pubmed: 36207703
J Affect Disord. 2015 Sep 01;183:247-52
pubmed: 26025371
Am J Orthopsychiatry. 2022;92(1):121-132
pubmed: 34914415
PLoS One. 2019 Apr 4;14(4):e0214804
pubmed: 30946774
Aten Primaria. 2016 Aug-Sep;48(7):449-57
pubmed: 26775265
J Clin Epidemiol. 2007 Jan;60(1):34-42
pubmed: 17161752
Nord J Psychiatry. 2003;57(2):113-8
pubmed: 12745773
Nord J Psychiatry. 2003;57(2):119-23
pubmed: 12745774
JAMA. 2016 Jan 26;315(4):380-7
pubmed: 26813211
Scand J Work Environ Health. 2011 Nov;37(6):551-5
pubmed: 21874209
Scand J Public Health. 2021 Feb;49(1):96-103
pubmed: 33251936
BMC Public Health. 2016 Jul 29;16:657
pubmed: 27473458
Psychol Methods. 2009 Mar;14(1):6-23
pubmed: 19271845
Int J Environ Res Public Health. 2021 May 28;18(11):
pubmed: 34071171
BMC Public Health. 2018 Jul 13;18(1):874
pubmed: 30005705
Soc Psychiatry Psychiatr Epidemiol. 1993 Jul;28(3):130-3
pubmed: 8378808
Int J Methods Psychiatr Res. 2022 Dec 3;:e1956
pubmed: 36461893
Fam Pract. 2011 Apr;28(2):233-7
pubmed: 20937663
BMJ Open. 2016 Nov 14;6(11):e012799
pubmed: 28137831
Heliyon. 2019 Aug 28;5(8):e02235
pubmed: 31497664
Fam Pract. 2018 Jan 16;35(1):1-3
pubmed: 29267903
Rev Psiquiatr Salud Ment (Engl Ed). 2018 Oct - Dec;11(4):216-226
pubmed: 27939026
BMC Res Notes. 2018 Jan 03;11(1):4
pubmed: 29298721
BMC Psychol. 2022 Mar 11;10(1):60
pubmed: 35277201